clinical trial · NCT00157963
Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)
Organon and Co·phase4·completed·n = 174
Essential HypertensionMK0954A; hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 weeks
brief summary
An efficacy and safety study of hydrochlorothiazide (+) losartan potassium compared to amlodipine at week 12 in Korean patients with essential hypertension
started
Feb 5, 2005
primary completion
Feb 8, 2006
completion
Feb 8, 2006
last updated
Aug 15, 2024
official title
A 12 Week, Open, Randomized, Parallel, Multicenter Study of Efficacy, Tolerability & Safety of Hydrochlorothiazide (+) Losartan Potassium Versus Amlodipine in Essential Hypertensive Patients.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol